![Cover image of the article: Synthesis and In Vitro Anti-Leishmanial Evaluation of 1 -( 5 - Halo- 2 -Thienyl)- 2 -[5 -(5-Nitroheteroaryl)]-1 ,3 ,4 -Thiadiazol- 2 - Ylthio)Ethanone Derivatives](https://brieflands.com/journals/jrps/articles/147768/figures/thumbnail.webp)
Synthesis and In Vitro Anti-Leishmanial Evaluation of 1 -( 5 - Halo- 2 -Thienyl)- 2 -[5 -(5-Nitroheteroaryl)]-1 ,3 ,4 -Thiadiazol- 2 - Ylthio)Ethanone Derivatives
Authors
Abstract
The Leishmaniasis is a zoonotic disease that remains a severe public health problem and its burden is increasing. By now there is no anti-leishmaniasis vaccine and as other tripanosomial disease, is treated by limited drugs. First line drug includes pentavalent antimony such as sodium stibogluconat and meglumine antimoniate that use of these drugs is limited due to side effects, long term treatment, high cost and incidence of drug resistance. It is clear that developing new, effective, cheap and safe drugs is necessary for treating Leishmaniasis. In this study new derivatives of 1-(5-halo-2-thienyl)-2-[5-(5- nitroheteroaryl)]-1,3,4-thiadiazol-2-ylthio)ethanone 8a-8d were synthesized and evaluated against the promastigote form of Leishmania major using MTT assay in comparison with control drug (Fluconazole). Concentrations (5-150 μg/mL) of synthesized compounds and control drug were prepared and IC50 for each compound was measured. IC50 for 8a-8d was 114.98 μM (44.59±8.15 μg/mL), 118.05 μM (51.25±9.08 μg/mL), 130.7 μM (52.78±12.97 μg/mL), and 252.7 μM (113.3±5.92 μg/mL) respectively that was less than of fluconazole 980 μM (300 μg/mL). The results of this study showed that four synthesized compounds had a significant effect on Leishmania major and have a stronger effect than control drug. It seems that these compounds can be used as an alternative in future.
Highlights
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major
Sadat-Ebrahimi SE, Mirmohammadi M, Mojallal Tabatabaei Z, Azimzadeh Arani M, Jafari-Ashtiani S, et al. Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Iran J Pharm Res. 2019;18(4):e124697. doi: https://doi.org/10.22037/ijpr.2019.14547.12476
Synthesis and Evaluation of Thiadiazole-based Antileishmanial Agents
Hassanzadeh F, Jafari E, Saeedi M, Saberi S. Synthesis and Evaluation of Thiadiazole-based Antileishmanial Agents. J Rep Pharm Sci. 2020;9(2):e147112. doi: https://doi.org/10.4103/jrptps.JRPTPS_3_20
![Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines](https://brieflands.com/journals/ijpr/articles/124964/figures/thumbnail.webp)
Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines
Foroumadi A, Adibi H, Kabudanian Ardestani S, Shirooie S, Bozorgomid A, et al. Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines. Iran J Pharm Res. 2017;16(3):e124964. doi: https://doi.org/10.22037/ijpr.2017.2071
Synthesis and Antimycobacterial Activity of some Triazole Derivatives–New Route to Functionalized Triazolopyridazines
Tehrani KHME, Mashayekhi V, Azerang P, Minaei S, Sardari S, et al. Synthesis and Antimycobacterial Activity of some Triazole Derivatives–New Route to Functionalized Triazolopyridazines. Iran J Pharm Res. 2015;14(Suppl):e125274. doi: https://doi.org/10.22037/ijpr.2015.1713
Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity
Aliabadi A, Hasanvand Z, Kiani A, Mirabdali SS. Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity. Iran J Pharm Res. 2013;12(4):e125741. doi: https://doi.org/10.22037/ijpr.2013.1363
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 2
Last Update: 1 week ago
- CrossRef: 0
Last Update: 8 hours ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 5 days ago